Dimethylamine

Dimethylamine

SCHEMBL1861764

CCCOc1cccc(C2=C3C=CC(=N3)C=C3C=CC(=N3)C(c3cccc(OCCC)c3)=C3C=CC(=N3)C=C3C=CC2=N3)c1.CNC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.38
▸ HDAC6 Q9UBN7 1/20 0.35
▸ MAPT P10636 4/20 0.35
▸ KMT2A Q03164 3/20 0.35
▸ ERN1 O75460 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ CYP1A2 P05177 2/20 0.34
▸ CYP2C9 P11712 2/20 0.34
▸ CYP2C19 P33261 2/20 0.34
▸ CYP19A1 P11511 1/20 0.34
▸ DHFR P00374 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.34
▸ LMNA P02545 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ GAA P10253 2/20 0.34
▸ HTT P42858 1/20 0.34
▸ CTSA P10619 1/20 0.34
▸ FABP1 P07148 1/20 0.33
▸ ALOX12 P18054 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL585273 0.85 MAOA (0.34) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2
SCHEMBL2325507 0.84 CYP1A2 (0.32) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2
SCHEMBL4745597 0.84 GRM5 (0.35) CYP1A2CYP2C19ALDH1A1CYP3A4CYP2D6
SCHEMBL2202844 0.84 TSHR (0.37) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2
Dimethylamine SCHEMBL1859717 0.84 DHODH (0.33) GAAFABP1
Hydrochloric Acid SCHEMBL584375 0.83 CHRNB2 (0.33) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2
SCHEMBL585529 0.82 CLK4 (0.39) KDM4EMAPTKMT2ACYP1A2CYP2C9
SCHEMBL2360345 0.78 CYP1A2 (0.32) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2
SCHEMBL28713240 0.78 PLA2G2A (0.36) —
Hydrochloric Acid SCHEMBL588718 0.78 CYP1A2 (0.33) CYP1A2CYP2C9CYP2C19CYP19A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8288528-B2 Meso-substituted porphyrins L. Molteni & C. Dei Fratelli Alitti—Società di Esercizio S.p.A. (IT) 2012-10-16 — — US disclosed
EP-1558616-B2 MESO-SUBSTITUTED PORPHYRINS MOLTENI & C (IT) 2011-08-24 — — EP disclosed
US-7947674-B2 Meso-substituted porphyrins L. Molteni & C. Dei Fratelli Alitti (IT) 2011-05-24 — — US disclosed
US-20110112464-A1 MESO-SUBSTITUTED PORPHYRINS L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A. (IT) 2011-05-12 — — US disclosed
EP-1558616-B1 MESO-SUBSTITUTED PORPHYRINS MOLTENI & C (IT) 2008-02-27 — — EP disclosed
US-20060040914-A1 Meso-substituted porphyrins L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A. (IT) 2006-02-23 — — US disclosed
EP-1558616-A2 MESO-SUBSTITUTED PORPHYRINS L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA' DI ESERCIZIO SOCIETA' PER AZIONI (IT) 2005-08-03 — — EP disclosed
WO-2004035590-A2 MESO-SUBSTITUTED PORPHYRINS L. MOLTENI & C. DEI FRATELLI ALITTI SOCIETA DI ESERCIZIO S.P.A (IT) 2004-04-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060040914-A1 Meso-substituted porphyrins PPOX, PPIF, ALAD KDM4E 4303/4885HDAC6 3770/4885MAPT 963/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback